Studies show that a low-dose of atropine, typically given as eye drops at bedtime, can slow the progression of myopia in children up to 59%, preventing severe nearsightedness. Research also shows that once atropine treatment stops, myopia progression can ramp up again. So, getting a diagnosis as early as possible and using atropine consistently through the eye’s growth years are key.